These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28843002)

  • 21. [Determination of HCV infection stage in a group of seropositive patients from Maracaibo, Venezuela by measurement the antibody avidity index of anti-HCV IgG].
    Cuadra Sánchez CA; Porto-Espinoza LD; Callejas-Monsalve DE; Moronta-Piñango RM; Mindiola-Morles RC; Atencio-Tello RJ
    Rev Gastroenterol Peru; 2007; 27(4):361-6. PubMed ID: 18183277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
    Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK
    Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay.
    Tillmann HL; Wiegand J; Glomb I; Jelineck A; Picchio G; Wedemeyer H; Manns MP
    Z Gastroenterol; 2005 Jan; 43(1):11-6. PubMed ID: 15650966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.
    Guobuzaite A; Chokshi S; Balciūniene L; Voinic A; Stikleryte A; Zagminas K; Ambrozaitis A; Naoumov N
    Medicina (Kaunas); 2008; 44(7):510-20. PubMed ID: 18695347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion.
    Katsoulidou AS; Moschidis ZM; Gialeraki RE; Paraskevis DN; Sypsa VA; Lazanas MC; Tassopoulos NC; Psichogiou MA; Boletis JN; Karafoulidou AS; Hatzakis AE
    Transfusion; 2004 Jan; 44(1):59-66. PubMed ID: 14692968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
    Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
    Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of enzyme-linked immunosorbent assays to test core antigen in the diagnosis and antiviral therapy management of hepatitis C virus infections.
    Wang L; Chen W; Xi W; Feng J; Dang P; Ma Y; Yu Y
    J Med Virol; 2017 Jul; 89(7):1235-1240. PubMed ID: 27958657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of low-avidity specific IgG antibody in the diagnosis of hepatitis C virus acute primary infection].
    Echevarría JM; Avellón A
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):706-7. PubMed ID: 21684043
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HCV immunoassays based on a multiepitope antigen and fluorescent lanthanide chelate reporters.
    Salminen T; Juntunen E; Khanna N; Pettersson K; Talha SM
    J Virol Methods; 2016 Feb; 228():67-73. PubMed ID: 26615808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.
    Boettiger DC; Law MG; Dore GJ; Guy R; Callander D; Donovan B; O'Connor CC; Fairley CK; Hellard M; Matthews G
    BMC Infect Dis; 2017 Dec; 17(1):740. PubMed ID: 29191154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative analysis of hepatitis C virus core protein in the plasma and serum samples from HCV-infected blood donors and patients with hepatitis C].
    Masalova OV; Vishnevskaia TV; Shkurko TV; Garanzha TA; Tupoleva TA; Filatov FP; Blokhina NP; Kushch AA
    Vopr Virusol; 2007; 52(4):11-7. PubMed ID: 17722604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.